Mindfulness-based meditation for tension-type headache
- Conditions
- chronic tension-type headacheNeurological - Other neurological disorders
- Registration Number
- ACTRN12610001039077
- Lead Sponsor
- niversity of South Australia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 60
Satisfying International Classification of Headache Disorders II (ICHD II) criteria for chronic tension-type headache.
No psychiatric or major medical condition currently or in the last 12 months, no con-current headache or pain symptoms or diagnoses (other than Tension Type Headache (TH) and Migraine). Additionally, headache subjects will required not to be taking, or not have taken in the last 3 months, regular analgesic medication other than less than or equal to 1000mg daily of aspirin or paracetamol for no more than 15 of 30 consecutive days.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Statistically significant reduction in headache severity compared to Control group. headache is recorded in a 2-wek diary by participants, yielding measures of intensity, duration, and days of headache. Headache severity is measured as average intensity or duration of headaches, or number of days headache.[6 weeks following randomization.]
- Secondary Outcome Measures
Name Time Method Statistically significant reduction in experimental acute pain sensitivity compared to Control group. pain is assessed as: <br>1) mean pressure pain detection threshold at finger or head (assessed by manual pressure algometer).<br>2) mean pain detection, intensity rating, and tolerance thresholds to cold pressor pain (assessed by immersing hand in cold water for up to 3 minutes).<br>3) mean muscle tenderness score (assessed by manual palpation of 7 extracephalic muscles bilaterally).<br>4) mean pain inhibition (assessed as the difference between pressure pain threshold at finger before and during contra-lateral painful occlusion cuff inflation).[6 weeks following randomization.]